Australia markets closed

JW Pharmaceutical Corporation (001067.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
59,000.00-300.00 (-0.51%)
At close: 03:30PM KST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
12,130,479
37,006,334
31,891,679
-967,850
-15,241,283
Depreciation & amortisation
22,574,598
22,574,598
16,836,320
16,111,747
20,688,165
Change in working capital
-20,262,513
-20,262,513
-6,169,670
-46,055,780
35,217,301
Inventory
8,916,798
8,916,798
-11,541,331
-2,655,110
-8,876,469
Other working capital
32,648,753
46,451,945
44,411,938
5,222,399
48,015,306
Other non-cash items
7,733,179
43,621,626
-1,384,929
6,084,828
7,990,973
Net cash provided by operating activities
46,345,604
87,157,236
56,764,439
18,123,982
63,054,367
Cash flows from investing activities
Investments in property, plant and equipment
-13,696,851
-40,705,291
-12,352,501
-12,901,583
-15,039,061
Acquisitions, net
-12,004,964
-12,004,964
-40,884
-948.48
-5,625,000
Purchases of investments
20,601,286
-61,344,003
-73,817,400
-140,023,467
-56,346,636
Sales/maturities of investments
26,043,311
69,604,030
47,473,709
141,101,743
16,641
Other investing activities
-44,706,265
-6,355,017
267,370
-44,540,628
501,187
Net cash used for investing activities
-21,783,918
-63,780,270
-18,919,160
-22,869,152
-79,427,292
Net change in cash
8,131,635
-17,989,057
531,448
22,915,136
-31,412,910
Cash at beginning of period
27,292,322
33,897,925
33,366,477
10,451,341
41,864,252
Cash at end of period
33,878,053
15,908,868
33,897,925
33,366,477
10,451,341
Free cash flow
Operating cash flow
46,345,604
87,157,236
56,764,439
18,123,982
63,054,367
Capital expenditure
-13,696,851
-40,705,291
-12,352,501
-12,901,583
-15,039,061
Free cash flow
32,648,753
46,451,945
44,411,938
5,222,399
48,015,306